Aspire Biopharma Holdings SEC Filing Effectiveness
Ticker: ASBP · Form: EFFECT · Filed: Apr 15, 2026
Sentiment: neutral
Topics: registration-statement, effectiveness, filing
TL;DR
Aspire Biopharma's registration statement is officially effective as of 4/14/2026.
AI Summary
Aspire Biopharma Holdings, Inc. filed an EFFECT form with the SEC on April 15, 2026, indicating the effectiveness of a registration statement. The effectiveness date was April 14, 2026. The company's mailing and business address is 23150 Fashion Drive, Suite 232, Estero, FL 33928.
Why It Matters
This filing signifies that Aspire Biopharma Holdings, Inc.'s registration statement is now effective, allowing for potential future stock offerings or transactions.
Risk Assessment
Risk Level: low — This is a procedural filing indicating the effectiveness of a registration statement, not a direct financial event.
Key Numbers
- 2026-04-15 — Filing Acceptance Date (Date the EFFECT filing was accepted by the SEC.)
- 2026-04-14 — Effectiveness Date (Date the registration statement became effective.)
Key Players & Entities
- Aspire Biopharma Holdings, Inc. (company) — Filer
- 23150 Fashion Drive, Suite 232 Estero FL 33928 (address) — Mailing and Business Address
- 0001847345 (company_id) — CIK
FAQ
What type of filing is this?
This is an EFFECT filing, which signifies the effectiveness of a registration statement.
When was the filing accepted by the SEC?
The filing was accepted on April 15, 2026.
What is the effectiveness date mentioned in the filing?
The effectiveness date is April 14, 2026.
What is the company's address?
The company's mailing and business address is 23150 Fashion Drive, Suite 232, Estero, FL 33928.
What is the CIK number for Aspire Biopharma Holdings, Inc.?
The CIK number for Aspire Biopharma Holdings, Inc. is 0001847345.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 15, 2026 regarding Aspire Biopharma Holdings, Inc. (ASBP).